Literature DB >> 30779083

MiR-202-3p functions as a tumor suppressor and reduces cell migration and invasion in papillary thyroid carcinoma.

J Chen1, J Yin, J Liu, R-X Zhu, Y Zheng, X-L Wang.   

Abstract

OBJECTIVE: MicroRNAs (miRNAs) are recently identified as key regulators of tumor development and progression. MiR-202-3p functions as tumor suppressor in some cancer types. The aim of the study is to determine its expression pattern and explore the functions underlying the mechanism of miR-202-3p in papillary thyroid carcinoma (PTC). PATIENTS AND METHODS: By using quantitative RT-PCR (QRT-PCR) analyses, we detected miR-202-3p expression in PTC tissues and cell lines. Transwell migration and invasion assays were performed to measure the migration and invasion ability of tumor cells transfected with miR-202-3p mimic. Western blot analysis was used to detect the protein expression.
RESULTS: Our results showed that miR-202-3p expression was frequently downregulated in 96 cases PTC tissues compared to adjacent normal tissues. Lower expression of miR-202-3p associated with lymph node metastasis of patients with PTC. Overexpression of miR-202-3p inhibited cell migration and invasion in TPC-1 and BCPAP cells. Furthermore, enforced expression of miR-202-3p inhibited WNT signaling by downregulating β-catenin expression in TPC-1 and BCPAP cells.
CONCLUSIONS: Our findings indicated that miR-202-3p may represent a novel therapeutic target of in PTC.

Entities:  

Year:  2019        PMID: 30779083     DOI: 10.26355/eurrev_201902_17005

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  9 in total

Review 1.  The microRNA-202 as a Diagnostic Biomarker and a Potential Tumor Suppressor.

Authors:  Emad A Ahmed; Peramaiyan Rajendran; Harry Scherthan
Journal:  Int J Mol Sci       Date:  2022-05-24       Impact factor: 6.208

2.  miR-202-3p negatively regulates MMP-1 to inhibit the proliferation, migration and invasion of lung adenocarcinoma cells.

Authors:  Yong Li; Huiqin Huang; Xiangli Ye; Zhenghui Huang; Xiangqi Chen; Feng Wu; Tingyan Lin
Journal:  Cell Cycle       Date:  2021-01-25       Impact factor: 4.534

3.  MicroRNA-203a-3p may prevent the development of thyroid papillary carcinoma via repressing MAP3K1 and activating autophagy.

Authors:  Lei Dai; Weidong Zhang; Xianjiang Wu; Shuihong Zhou
Journal:  J Clin Lab Anal       Date:  2022-05-06       Impact factor: 3.124

Review 4.  Exosomal miRNA: Small Molecules, Big Impact in Colorectal Cancer.

Authors:  Valentin Vautrot; Gaëtan Chanteloup; Mohammed Elmallah; Marine Cordonnier; François Aubin; Carmen Garrido; Jessica Gobbo
Journal:  J Oncol       Date:  2019-10-13       Impact factor: 4.375

5.  lncRNA HOTAIRM1 regulates cell proliferation and the metastasis of thyroid cancer by targeting Wnt10b.

Authors:  Chenyao Li; Xinxin Chen; Tao Liu; Guang Chen
Journal:  Oncol Rep       Date:  2020-12-31       Impact factor: 3.906

Review 6.  MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment.

Authors:  Maria Papaioannou; Angeliki G Chorti; Anthoula Chatzikyriakidou; Kleanthis Giannoulis; Sohail Bakkar; Theodosios S Papavramidis
Journal:  Front Oncol       Date:  2022-02-03       Impact factor: 6.244

7.  Blood microRNA 202-3p associates with the risk of essential hypertension by targeting soluble ST2.

Authors:  Lu Li; Danrong Zhong; Yudan Xie; Xinlei Yang; Zuozhong Yu; Dangui Zhang; Xinghua Jiang; Yanqing Wu; Fangqin Wu
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

8.  lncRNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 Promotes Proliferation and Invasion of Non-Small Cell Lung Cancer Cells via Down-Regulating miR-202 Expression.

Authors:  Guo Tiansheng; Huang Junming; Wan Xiaoyun; Chen Peixi; Du Shaoshan; Chen Qianping
Journal:  Cell J       Date:  2019-12-15       Impact factor: 2.479

9.  MicroRNA‑202 inhibits endometrial stromal cell migration and invasion by suppressing the K‑Ras/Raf1/MEK/ERK signaling pathway.

Authors:  Di Zhang; Ling Wang; Hua-Lei Guo; Zi-Wei Zhang; Chong Wang; Ri-Cheng Chian; Zhi-Fen Zhang
Journal:  Int J Mol Med       Date:  2020-10-09       Impact factor: 4.101

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.